Scientific Literature
Published
Research.
Browse peer-reviewed studies and clinical trials on compounds in our catalogue. All citations link directly to PubMed or official journal sources. For educational purposes only.
RetatrutideTriple GIP/GLP-1/Glucagon Agonist
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2 Trial
- Retatrutide for people with type 2 diabetes: a randomised, double-blind trial
- Efficacy and safety of LY3437943 (retatrutide) in obesity
- TRIUMPH-3: Phase 3 Study in Adults With Obesity
SemaglutideGLP-1 Receptor Agonist
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
- Two-Year Effects of Semaglutide in Adults (STEP 5)
- Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes
- Effect of Weekly Semaglutide vs Daily Liraglutide (STEP 8)
TirzepatideDual GIP/GLP-1 Agonist
- Tirzepatide Once Weekly for Treatment of Obesity (SURMOUNT-1)
- Tirzepatide vs Semaglutide Once Weekly (SURPASS-2)
- Tirzepatide for Type 2 Diabetes and BMI ≥27
- Tirzepatide vs Insulin Glargine (SURPASS-4)
CagrilintideAmylin Analogue
- Once-Weekly Cagrilintide for Weight Management in People with Overweight
- CagriSema: cagrilintide plus semaglutide in obesity
- Cagrilintide as add-on to insulin in type 2 diabetes
MazdutideGLP-1/Glucagon Dual Agonist
- Mazdutide once weekly in Chinese adults with overweight or obesity
- Mazdutide Phase 2b trial for treatment of type 2 diabetes
- Phase 3 Study of Mazdutide in Obesity
SurvodutideGLP-1/Glucagon Dual Agonist
AOD 9604GH Fragment 177-191
- AOD9604: a novel lipolytic peptide
- Anti-obesity effects of GH fragment 177-191
- AOD9604 effects on body fat in obese adults
BPC-157Body Protection Compound
- Stable gastric pentadecapeptide BPC 157: novel therapy in GI tract
- BPC 157 and standard angiogenic growth factors
- BPC 157 enhances growth hormone receptor in tendon fibroblasts
- BPC 157 in trials for inflammatory bowel disease
TB-500Thymosin Beta-4 Fragment
- Thymosin β4 promotes wound healing via VEGF secretion
- Thymosin beta 4 and cardiac repair
- Thymosin β4 activates integrin-linked kinase
- Thymosin β4 promotes angiogenesis and regeneration
GHK-CuCopper Tripeptide
- GHK-Cu prevents oxidative stress in skin
- GHK Peptide as Modulator of Skin Regeneration
- Tripeptide-copper stimulates collagen synthesis
- GHK-Cu promotes wound healing via fibroblasts
Thymosin Alpha-1Immunomodulator
- Thymosin alpha 1 for immunodeficiency treatment
- Thymalfasin as immune response modifier
- Thymosin α1 clinical applications in viral hepatitis
LL-37Antimicrobial Peptide
- LL-37: structure, function, and regulation
- LL-37 and wound healing mechanisms
- Cathelicidin LL-37 immunomodulatory functions
KPVα-MSH C-Terminal Fragment
- KPV tripeptide anti-inflammatory activity
- KPV peptide in intestinal inflammation
- α-MSH fragments inhibit inflammatory response
SS-31Elamipretide / Mitochondrial Peptide
SemaxNootropic Heptapeptide
- Semax activates dopaminergic and serotoninergic systems
- Semax: analogue with nootropic and neuroprotective properties
- Comparative study of nootropic effects of Semax derivatives
- Semax affects immune and vascular gene expression
SelankAnxiolytic Peptide
- Selank inhibits enkephalin-degrading enzymes
- Selank anxiolytic effect without addiction potential
- Selank affects GABAergic neurotransmission genes
- Anxiolytic mechanisms of Selank
N-Acetyl Semax AmidateEnhanced Semax Analogue
- Semax affects expression of immune genes
- Nootropic effects of Semax derivatives
- ACTH(4-10) analogue brain system activation
N-Acetyl Selank AmidateEnhanced Selank Analogue
- Selank affects GABAergic neurotransmission genes
- Anxiolytic activity and mechanisms of Selank
- Tuftsin analogue peptide properties
DSIPDelta Sleep-Inducing Peptide
- DSIP: biosynthesis, release and physiological effects
- DSIP: endogenous sleep-promoting factor
- DSIP immunoreactivity in hypothalamus
CerebrolysinNeurotrophic Peptide Mix
- Cerebrolysin in acute ischemic stroke
- Cerebrolysin in traumatic brain injury
- Cerebrolysin neuroprotective mechanisms
PE-22-28Spadin Analogue / TREK-1 Blocker
- Spadin antidepressant properties via TREK-1 blockade
- TREK-1 as antidepressant target
- TREK-1 channel blockers as antidepressants
P21CNTF-Derived Peptide
- P21 peptide and neurogenesis in Alzheimer’s model
- CNTF-derived peptide effects on cognition
- P21 enhances synaptic plasticity
EpithalonTelomerase Activator
GlutathioneMaster Antioxidant Tripeptide
CJC-1295 No DACShort-Acting GHRH Analogue
CJC-1295 With DACLong-Acting GHRH Analogue
IpamorelinSelective GH Secretagogue
TesamorelinModified GHRH Analogue
GHRP-2Growth Hormone Releasing Peptide-2
IGF-1 LR3Long R3 Insulin-Like Growth Factor
MGFMechano Growth Factor
PEG-MGFPEGylated Mechano Growth Factor
Melanotan IIα-MSH Analogue
- Melanotan II: synthetic α-MSH analogue for pigmentation
- MC1R variants, UV radiation and melanogenesis
- The melanocortin system and skin pigmentation
- MSH analogue induces tanning in humans
PT-141Bremelanotide / MC4R Agonist
- PT-141 for sexual dysfunction — early trials
- Bremelanotide for hypoactive sexual desire disorder
- Bremelanotide Phase 3 efficacy trial
Kisspeptin-10GnRH Neuron Activator
- Kisspeptin and the control of reproduction
- Kisspeptin and the neuroendocrine control of reproduction
- Kisspeptin stimulates gonadotropin release in humans
No compounds match your search. Try a different term or .
Educational Disclaimer: The peer-reviewed studies and clinical trials listed above are provided solely for informational and educational purposes. AurumLabs does not make any therapeutic, medical, or health claims about its products. All compounds are intended exclusively for in-vitro and in-vivo laboratory research conducted by qualified researchers. Nothing on this page constitutes medical advice. Researchers are responsible for ensuring compliance with all applicable regulations in their jurisdiction.